| CAS NO: | 196808-45-4 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 5mg | 电议 |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
Farglitazar (GI-262570; GI262570) is a novel and potent PPAR-γ agonist with the potential to be used for glycemic control in type 2 diabetic patients. It can increase water and sodium reabsorption in distal nephron by stimulating the ENaC and Na,K-ATPase system.
纯度：≥98%
CAS：196808-45-4
m.cnreagent.com